Cargando…

Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma

Objective: The molecular classification for endometrial cancer (EC) introduced by The Cancer Genome Atlas Research Network (TCGA) and the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) proved the existence of four molecular prognostic subtypes; however, both classifications req...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bounous, Valentina Elisabetta, Ferrero, Annamaria, Campisi, Paola, Fuso, Luca, Pezua Sanjinez, Jeremy Oscar Smith, Manassero, Sabrina, De Rosa, Giovanni, Biglia, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571045/ https://www.ncbi.nlm.nih.gov/pubmed/36233549 http://dx.doi.org/10.3390/jcm11195678

Ejemplares similares

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
por: Tuninetti, Valentina, et al.
Publicado: (2023)

Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022)

Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy
por: D’Alonzo, Marta, et al.
Publicado: (2019)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study
por: Pace, Luca, et al.
Publicado: (2022)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Immunohistochemical Markers in Endometrial Cancer
por: Mais, Valerio, et al.
Publicado: (2021)

Clinical, Pathological, and Prognostic Features of Male Breast Cancer: A Multicenter Study
por: Accomasso, Francesca, et al.
Publicado: (2023)

Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population
por: Bounous, Valentina Elisabetta, et al.
Publicado: (2022)

Immunonutrition in ovarian cancer: clinical and immunological impact?
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update
por: Biglia, Nicoletta, et al.
Publicado: (2019)

The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study
por: Villasco, Andrea, et al.
Publicado: (2021)

Immunohistochemical Markers in Endometrial Cancer: Latest Updates
por: Mais, Valerio, et al.
Publicado: (2023)

Predicting Response to Anthracyclines in Ovarian Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
por: Salama, Amany, et al.
Publicado: (2019)

Fysikkpris til Fanamann
Publicado: (1981)

Petabytes til folket
Publicado: (2005)

Goldilocks and the three TILs
por: Dada, Hannah, et al.
Publicado: (2022)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
por: Arnaud, Marion, et al.
Publicado: (2023)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.
por: Palomero, Jara, et al.
Publicado: (2022)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

Rejsen til universets indre
por: Kjaer, C
Publicado: (1998)

Blue Light Til Dawn/
por: Cassandra Wilson

Nedtelling til tidenes stjernesmell
Publicado: (2008)

Verden står til Jul
Publicado: (2009)

Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
por: Al-Rajhi, Nasser, et al.
Publicado: (2021)

Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
por: Jiang, Peng, et al.
Publicado: (2020)

Comparative Study on the Larvicidal Activity of Drimane Sesquiterpenes and Nordrimane Compounds against Drosophila melanogaster til-til
por: Montenegro, Ivan, et al.
Publicado: (2013)

tilS and rpoB: New Molecular Markers for Phylogenetic and Biodiversity Studies of the Genus Thiothrix
por: Ravin, Nikolai V., et al.
Publicado: (2023)

CERN-anlegg til to milliarder planglagt
por: Sundar, E
Publicado: (1964)

Pumpemotstand for vakuumkammer til CERN PS
Publicado: (1952)

Jaktar på gåtene til universet
por: Toft, Martin
Publicado: (2004)

Cern fik protoner til at kollidere
Publicado: (2009)

Klar til et langt år
Publicado: (2010)

A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
por: Weinberger, Vit, et al.
Publicado: (2019)

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
por: Alabanza, Leah, et al.
Publicado: (2014)

Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas
por: Subbaraya, Sneha, et al.
Publicado: (2020)

Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8
por: Hernandez-Caballero, Ana I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uefrrge0pr8kh8ogt0c510rjm3